59 results about "Spinal canal stenosis" patented technology

It relates to an endogenous repair factor production accelerator which comprises one or at least two selected from prostaglandin (PG) 12 agonist, EP2 agonist and EP4 agonist. Since prostaglandin (PG) 12 agonist, EP2 agonist or EP4 agonist has various endogenous repair factor production accelerating action, angiogenesis acceleration action and stem cell differentiation induction action, it is useful as preventive and / or therapeutic agents for ischemic organ diseases (e.g., arteriosclerosis obliterans, Buerger disease, Raynaud disease, myocardial infarction, angina pectoris, diabetic neuropathy, spinal canal stenosis, cerebrovascular accidents, cerebral infarction, pulmonary hypertension, bone fracture, Alzheimer disease, etc.) and various cell and organ diseases.

The invention relates to a dynamic non-fusion connector which belongs to the field of medical apparatuses. The dynamic non-fusion connector is matched with spinal screws and used for treating diseases of spinal instability, deformity, spondylolisthesis, spinal canal stenosis, fracture, and the like. The dynamic non-fusion connector comprises a spring shaft (1), a limit sleeve (2), a limit core (3), a stud (4) and a fixed shaft (5) and is characterized in that the left end of the spring shaft (1) adopts a polished rod design and is provided with an internal thread through hole, and the right end of the spring shaft (1) adopts an annular spring structure and is provided with a step hole, and gaps and small circular holes are arranged among rings of the annular spring structure; and a tapered face, a step cylinder surface and a notch are arranged on the outer surface of the limit sleeve (2), and a step through-hole is arranged in the center of the limit sleeve (2). An application method of the dynamic on-fusion connector comprises the following steps of: firstly determining the embedded depth and orientation of the spinal screws and the length of the dynamic non-fusion connector, drilling a hole, holding the spinal screw, embedding into a vertebral body, embedding other spinal screws, then embedding the dynamic non-fusion connector, screwing a top thread in, and compressing the dynamic non-fusion connector to a final locking position so as to realize the dynamic non-fusion fixing of a system.

A Chinese medicine 'Danlue tablet' for treating lumbar spinal canal stenosis is proportionally prepared from red sage root, antler glue, astragalus root, corydalis tuber and eucommia bark through preparing the extract of astragalus root and eucommia bark by decocting and concentrating, adding antler glue, preparing the extract of red sage root and corydalis tuber by alcohol reflux and concentrating, mixing them together, granulating, drying, pulverizing, tablet pressing and coating.

The invention discloses Chinese medicine bone-setting powder based on the hot salt method for remedying rheumatoid bone disease. The bone-setting powder is prepared from 5 to 15 percent of millettia reticulat and fumitory, 8 to 17 percent of wild celery, 3 to 9 percent of frankincense and morinda officinalis, 6 to 13 percent of myrrh and rhizoma ligustici wallichii, 7 to 15 percent of rhizoma drynariae, 5 to 13 percent of cistanche salsa, 3 to 8 percent of borneol and 10 to 12 percent of safflower. The material is ground into coarse powder; put into a pure cotton cloth bag and then sealed forthermohaline applying treatment. The invention has the effects of expelling wind and removing damness, trimming bruise, promoting blood circulation and relaxing tendon. The invention has obvious effect on rheumatism, rheumatoid, scapulohumeral periathritis, limb numbness, lumbocrural pain, hyperosteogeny, spinal canal stenosis, proplapse of intervertebral discsciatica, nonunion and aseptic osteonecrosis and no toxic side effects.